Sertraline Hydrochloride Tablet Market to Record Significant Revenue Growth during the Forecast Period 2020–2025 | PIDI, Cy Pharm, Pfizer, Accord-Healthcare, Exelan, Greenstone, Cipla, Lupins

This report provides in-depth study on the current state of the Global Sertraline Hydrochloride Tablet Market 2020-2025. Key players in the Global Sertraline Hydrochloride Tablet Market have been identified through the secondary research and their market share has been determined through primary and secondary research.

Global Sertraline Hydrochloride Tablet Market overview:

Sertraline hydrochloride is supplied for oral administration as scored tablets containing sertraline hydrochloride equivalent to 25, 50 and 100 mg of sertraline. Sertraline hydrochloride is a selective serotonin reuptake inhibitor (SSRI) for oral administration. It has a molecular weight of 342.7. Sertraline hydrochloride has the following chemical name: (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride. Sertraline hydrochloride is a white crystalline powder that is slightly soluble in water and isopropyl alcohol and sparingly soluble in ethanol. The Global Sertraline Hydrochloride Tablet Market is segmented on the basis of Product Type, Application, End Use Industry and Region. This report also covers all the regions and countries of the world, which shows a regional development status, including market size.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/275711 .

On the Basis of Product Type segment, the Sertraline Hydrochloride Tablet Market is sub segmented into Generic Grugs, Patent Medicine and Others. Based on End Use Industry segment, the Sertraline Hydrochloride Tablet Market is segmented as Treat Depression, Treat Obsessive-Compulsive Disorder, Treat Anxiety and Others.

There are several manufacturers of Sertraline Hydrochloride Tablet in Europe and North America. In North America, the demand for Sertraline Hydrochloride Tablet is primarily driven by the Healthcare sector. Among the countries in Asia Pacific, the demand was substantially high in developing countries such as China and India.

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Sertraline Hydrochloride Tablet Market Report 2020” @ https://www.businessindustryreports.com/buy-now/275711/single .

Top Industry News:

Lupin Launches Lapatinib Tablets on 30 September, 2020 -- Pharma major Lupin Limited (Lupin) announced today the launch of Lapatinib Tablets, 250 mg, after Lupin’s alliance partner Natco Pharma Ltd received final approval for its ANDA from the United States Food and Drug Administration (U.S. FDA).

Lapatinib Tablets, 250 mg, are the generic equivalent of Tykerb Tablets, 250 mg, of Novartis Pharmaceutical Corporation, and are indicated in combination with:

Capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress human epidermal growth factor receptor 2 (HER2), and who have received prior therapy including an anthracycline, a taxane and trastuzumab

Letrozole for the treatment of postmenopausal women with hormone-receptor positive metastatic breast cancer that overexpresses the HER2 receptor, for whom hormonal therapy is indicated

Lapatinib Tablets (RLD: Tykerb) had annual sales of approximately USD 61 million in the U.S. (IQVIA MAT June 2020).

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/275711 .

Major Key Players:

Some of the Sertraline Hydrochloride Tablet Market manufacturers involved in the market are PIDI, Cy Pharm, HENGSHAN PHARMACEYTICAL, JINGXIN PHARMACEUTICAL, Hainan Healthcare Pharma, Pfizer, Accord-Healthcare, Exelan Pharmaceuticals, Greenstone, Cipla USA Lnc, Lupin in World, effective mergers are some of the strategies adopted by the Sertraline Hydrochloride Tablet Market manufacturers. New product launches and continuous technological innovations are the Sertraline Hydrochloride Tablet Market strategies adopted by the major players.

Table of Contents:

1 Sertraline Hydrochloride Tablet Product Definition
2 Global Sertraline Hydrochloride Tablet Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Sertraline Hydrochloride Tablet Shipments
2.2 Global Manufacturer Sertraline Hydrochloride Tablet Business Revenue
2.3 Global Sertraline Hydrochloride Tablet Market Overview
3 Manufacturer Sertraline Hydrochloride Tablet Business Introduction
3.1 PIDI Sertraline Hydrochloride Tablet Business Introduction
3.1.1 PIDI Sertraline Hydrochloride Tablet Shipments, Price, Revenue and Gross profit 2020-2025
3.1.2 PIDI Sertraline Hydrochloride Tablet Business Distribution by Region
3.1.3 PIDI Interview Record
3.1.4 PIDI Sertraline Hydrochloride Tablet Business Profile
3.1.5 PIDI Sertraline Hydrochloride Tablet Product Specification
3.2 Cy Pharm Sertraline Hydrochloride Tablet Business Introduction
3.2.1 Cy Pharm Sertraline Hydrochloride Tablet Shipments, Price, Revenue and Gross profit 2020-2025
3.2.2 Cy Pharm Sertraline Hydrochloride Tablet Business Distribution by Region
3.2.3 Interview Record
3.2.4 Cy Pharm Sertraline Hydrochloride Tablet Business Overview
3.2.5 Cy Pharm Sertraline Hydrochloride Tablet Product Specification
3.3 HENGSHAN PHARMACEYTICAL Sertraline Hydrochloride Tablet Business Introduction
3.3.1 HENGSHAN PHARMACEYTICAL Sertraline Hydrochloride Tablet Shipments, Price, Revenue and Gross profit 2020-2025
3.3.2 HENGSHAN PHARMACEYTICAL Sertraline Hydrochloride Tablet Business Distribution by Region
3.3.3 Interview Record
3.3.4 HENGSHAN PHARMACEYTICAL Sertraline Hydrochloride Tablet Business Overview
3.3.5 HENGSHAN PHARMACEYTICAL Sertraline Hydrochloride Tablet Product Specification
3.4 JINGXIN PHARMACEUTICAL Sertraline Hydrochloride Tablet Business Introduction
3.5 Hainan Healthcare Pharma Sertraline Hydrochloride Tablet Business Introduction
3.6 Pfizer Sertraline Hydrochloride Tablet Business Introduction

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.